UFF
ANIP icon

USA Financial Formulas’s ANI Pharmaceuticals ANIP Stock Holding History

USA Financial Formulas’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-49
Closed -$2.85K – 353
2023
Q3 		$2.85K Sell
49
-5
-9% -$289 ﹤0.01% 306
2023
Q2 		$2.91K Buy
+54
New +$2.39K ﹤0.01% 272
2019
Q4 		– Sell
-7
Closed -$1K – 226
2019
Q3 		$1K Buy
+7
New +$524 ﹤0.01% 190
2015
Q1 		– Sell
-10,446
Closed -$589K – 184
2014
Q4 		$589K Buy
+10,446
New +$461K 0.2% 92

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

USA Financial Formulas's ANIP Position: Q4 2023 in Review

USA Financial Formulas sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 49 shares — an estimated $2.85K sold.

USA Financial Formulas first reported a position in ANIP in Q4 2014 and held it in 4 quarters. The position peaked at $589K in Q4 2014. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • USA Financial Formulas reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • USA Financial Formulas sold 49 ANI Pharmaceuticals shares in Q4 2023, an estimated $2.85K.
  • USA Financial Formulas first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • USA Financial Formulas's ANI Pharmaceuticals position peaked at $589K in Q4 2014.
  • 181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.